Structural Basis of GD2 Ganglioside and Mimetic Peptide Recognition by 14G2a Antibody.
Horwacik, I., Golik, P., Grudnik, P., Kolinski, M., Zdzalik, M., Rokita, H., Dubin, G.(2015) Mol Cell Proteomics 14: 2577-2590
- PubMed: 26179345 
- DOI: 10.1074/mcp.M115.052720
- Primary Citation of Related Structures:  
4TRP, 4TUJ, 4TUK, 4TUL, 4TUO - PubMed Abstract: 
Monoclonal antibodies targeting GD2 ganglioside (GD2) have recently been approved for the treatment of high risk neuroblastoma and are extensively evaluated in clinics in other indications. This study illustrates how a therapeutic antibody distinguishes between different types of gangliosides present on normal and cancer cells and informs how synthetic peptides can imitate ganglioside in its binding to the antibody ...